메뉴 건너뛰기




Volumn 59, Issue 5, 2004, Pages 1405-1413

Assessment of i-125 prostate implants by tumor bioeffect

Author keywords

Dosimetry; I 125 implants; Prostate cancer; Radiobiology; Tumor control probability

Indexed keywords

TUMOR BIOEFFECTS; TUMOR CONTROL PROBABILITY (TCP);

EID: 3242662008     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.01.047     Document Type: Article
Times cited : (23)

References (29)
  • 2
    • 0032972089 scopus 로고    scopus 로고
    • Defining the implant treatment volume for patients with low risk prostate cancer: Does the anterior base need to be treated?
    • D'Amico A.V., Davis A., Vargas S.O., et al. Defining the implant treatment volume for patients with low risk prostate cancer Does the anterior base need to be treated? Int J Radiat Oncol Biol Phys. 43:1999;587-590
    • (1999) Int J Radiat Oncol Biol Phys , vol.43 , pp. 587-590
    • D'Amico, A.V.1    Davis, A.2    Vargas, S.O.3
  • 4
    • 0034667653 scopus 로고    scopus 로고
    • Detailed mapping of prostate carcinoma foci: Biopsy strategy implications
    • Chen M.E., Johnston D.A., Tang K., et al. Detailed mapping of prostate carcinoma foci Biopsy strategy implications. Cancer. 89:2000;1800-1809
    • (2000) Cancer , vol.89 , pp. 1800-1809
    • Chen, M.E.1    Johnston, D.A.2    Tang, K.3
  • 5
  • 7
    • 0032913909 scopus 로고    scopus 로고
    • Fractionation and protraction for radiotherapy of prostate carcinoma
    • Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 43:1999;1095-1101
    • (1999) Int J Radiat Oncol Biol Phys , vol.43 , pp. 1095-1101
    • Brenner, D.J.1    Hall, E.J.2
  • 8
    • 0036140325 scopus 로고    scopus 로고
    • Direct evidence that prostate tumours show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue
    • Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumours show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys. 52:2002;6-13
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , pp. 6-13
    • Brenner, D.J.1    Martinez, A.A.2    Edmundson, G.K.3
  • 10
    • 0033026882 scopus 로고    scopus 로고
    • What is the α/β ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy
    • Duchesne G.M., Peters L.J. What is the α/β ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 44:1999;747-748
    • (1999) Int J Radiat Oncol Biol Phys , vol.44 , pp. 747-748
    • Duchesne, G.M.1    Peters, L.J.2
  • 12
    • 0035450897 scopus 로고    scopus 로고
    • A simple analytic derivation suggests that prostate cancer α/β ratio is low
    • King C.R., Fowler J.F. A simple analytic derivation suggests that prostate cancer α/β ratio is low. Int J Radiat Oncol Biol Phys. 51:2001;213-214
    • (2001) Int J Radiat Oncol Biol Phys , vol.51 , pp. 213-214
    • King, C.R.1    Fowler, J.F.2
  • 13
    • 0034183792 scopus 로고    scopus 로고
    • Is the prostate α/β ratio of 1.5 from Brenner & Hall a modelling artefact?
    • King C., Mayo C.S. Is the prostate α/β ratio of 1.5 from Brenner & Hall a modelling artefact? Int J Radiat Oncol Biol Phys. 47:2000;536-538
    • (2000) Int J Radiat Oncol Biol Phys , vol.47 , pp. 536-538
    • King, C.1    Mayo, C.S.2
  • 14
    • 0037458373 scopus 로고    scopus 로고
    • The influence of brachytherapy dose heterogeneity on estimates of α/β for prostate cancer
    • Lindsay P.E., Moiseenko V.V., Van Dyk J., Battista J.J. The influence of brachytherapy dose heterogeneity on estimates of α/β for prostate cancer. Phys Med Biol. 48:2003;507-522
    • (2003) Phys Med Biol , vol.48 , pp. 507-522
    • Lindsay, P.E.1    Moiseenko, V.V.2    Van Dyk, J.3    Battista, J.J.4
  • 15
    • 0042383102 scopus 로고    scopus 로고
    • How low is the α/β ratio for prostate cancer? in regard to Wang, et al
    • Fowler J.F., Chappell R.J. How low is the α/β ratio for prostate cancer? In regard to Wang, et al. Int J Radiat Oncol Biol Phys. 57:2003;593-595
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , pp. 593-595
    • Fowler, J.F.1    Chappell, R.J.2
  • 16
    • 0041381048 scopus 로고    scopus 로고
    • Low α/β ratio for prostate cancer: In response to Dr Fowler, et al
    • Wang J.Z., Guerrero M., Li X.A. Low α/β ratio for prostate cancer in response to Dr Fowler, et al. Int J Radiat Oncol Biol Phys. 57:2003;595-596
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , pp. 595-596
    • Wang, J.Z.1    Guerrero, M.2    Li, X.A.3
  • 17
    • 0034487516 scopus 로고    scopus 로고
    • Registration of prostate volume with radiographically identified I-125 seeds for permanent implant evaluation
    • Haworth A., Ebert M., Joseph D., Kaye K. Registration of prostate volume with radiographically identified I-125 seeds for permanent implant evaluation. J Brachytherapy Int. 16:2000;157-167
    • (2000) J Brachytherapy Int , vol.16 , pp. 157-167
    • Haworth, A.1    Ebert, M.2    Joseph, D.3    Kaye, K.4
  • 18
    • 0028919251 scopus 로고
    • Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43
    • Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys. 22:1995;209-234
    • (1995) Med Phys , vol.22 , pp. 209-234
    • Nath, R.1    Anderson, L.L.2    Luxton, G.3
  • 19
    • 0034089299 scopus 로고    scopus 로고
    • Modelling dose-response in the presence of spatial variations in dose-rate
    • Ebert M., Zavgorodni S. Modelling dose-response in the presence of spatial variations in dose-rate. Med Phys. 27:2000;393-400
    • (2000) Med Phys , vol.27 , pp. 393-400
    • Ebert, M.1    Zavgorodni, S.2
  • 20
    • 0029763734 scopus 로고    scopus 로고
    • Dose rate effects in targeted radiotherapy
    • Dale R.G. Dose rate effects in targeted radiotherapy. Phys Med Biol. 41:1996;1871-1884
    • (1996) Phys Med Biol , vol.41 , pp. 1871-1884
    • Dale, R.G.1
  • 21
    • 0027223126 scopus 로고
    • A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density
    • Webb S., Nahum A.E. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol. 38:1993;653-666
    • (1993) Phys Med Biol , vol.38 , pp. 653-666
    • Webb, S.1    Nahum, A.E.2
  • 22
    • 0028073266 scopus 로고
    • Optimum parameters in a model for tumour control probability including interpatient heterogeneity
    • Webb S. Optimum parameters in a model for tumour control probability including interpatient heterogeneity. Phys Med Biol. 39:1994;1895-1914
    • (1994) Phys Med Biol , vol.39 , pp. 1895-1914
    • Webb, S.1
  • 23
    • 0042884208 scopus 로고    scopus 로고
    • Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the α/β ratio
    • Nahum A.E., Movsas B., Horwitz E.M., et al. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer Implications for the α/β ratio. Int J Radiat Oncol Biol Phys. 57:2003;391-401
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , pp. 391-401
    • Nahum, A.E.1    Movsas, B.2    Horwitz, E.M.3
  • 24
    • 0036471914 scopus 로고    scopus 로고
    • Prostate brachytherapy postimplant dosimetry: A comparison of prostate quadrants
    • Sidhu S., Morris W.J., Spadinger I., et al. Prostate brachytherapy postimplant dosimetry a comparison of prostate quadrants. Int J Radiat Oncol Biol Phys. 52:2002;544-552
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , pp. 544-552
    • Sidhu, S.1    Morris, W.J.2    Spadinger, I.3
  • 25
    • 0035668665 scopus 로고    scopus 로고
    • Sector analysis of prostate implants
    • Bice W.S., Prestidge B.R., Sarosdy M.F. Sector analysis of prostate implants. Med Phys. 28:2001;2561-2567
    • (2001) Med Phys , vol.28 , pp. 2561-2567
    • Bice, W.S.1    Prestidge, B.R.2    Sarosdy, M.F.3
  • 26
    • 0035889359 scopus 로고    scopus 로고
    • Fitting of tumour control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: Pitfalls in deducing radiobiological parameters for tumours from clinical data
    • Levegrun S., Jackson A., Zelefsky M.J., et al. Fitting of tumour control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer pitfalls in deducing radiobiological parameters for tumours from clinical data. Int J Radiat Oncol Biol Phys. 4:2001;1064-1080
    • (2001) Int J Radiat Oncol Biol Phys , vol.4 , pp. 1064-1080
    • Levegrun, S.1    Jackson, A.2    Zelefsky, M.J.3
  • 27
    • 0032912743 scopus 로고    scopus 로고
    • The delta-TCP concept: A clinically useful measure of tumour control probability
    • Sanchez-Nieto B., Nahum A.E. The delta-TCP concept A clinically useful measure of tumour control probability. Int J Radiat Oncol Biol Phys. 44:1999;369-380
    • (1999) Int J Radiat Oncol Biol Phys , vol.44 , pp. 369-380
    • Sanchez-Nieto, B.1    Nahum, A.E.2
  • 28
    • 0032588023 scopus 로고    scopus 로고
    • Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer
    • Zelefsky M.J., Wallner K.E., Ling C.C., et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J. Clin Oncol. 17:1999;517-522
    • (1999) J. Clin Oncol , vol.17 , pp. 517-522
    • Zelefsky, M.J.1    Wallner, K.E.2    Ling, C.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.